Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
brown tumor
calcification, intracranial
CAT scan, abnormal
electroencephalogram, abnormalities of
hyperparathyroidism
hyperparathyroidism, secondary
hyperphosphatasia
impotence
muscle pain
muscle weakness
muscle weakness, proximal
myopathy
nerve conduction studies
nerve conduction studies, motor
neuroendocrinology
osteomalacia
pain, back
paraplegia
paraplegia, acute
parathormone
polyneuropathy
polyneuropathy, uremic
renal failure
spinal cord, compression of
uremia
weakness, generalized
weakness, proximal
Showing articles 350 to 400 of 894 << Previous Next >>

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003

Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003

Secondary Prevention of Stroke in Italy
Stroke 34:1010-1014, Filippi,A.,et al, 2003

Palinopsia
Lancet 361:1098, Smith,P.E.M.,et al, 2003

Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke Among the Elderly
NEJM 348:1322-1332, Nichol,K.L.,et al, 2003

Blood Pressure-Lowering for Secondary Prevention of Stroke: ACE Inhibition Is Not the Key
Stroke 34:1334-1335,1335, Bath,P., 2003

Blood Pressure--Lowering for Secondary Prevention of Stroke: ACE Inhibition Is the Key
Stroke 34:1333-1334,1334, Anderson,C., 2003

Should Asymptomatic Patients with Hereditary Haemorrhagic Telangiectasia (HHT) be Screened for Cerebral Vascular Malformations? Data from 22 061 years of HHT Patient Life
JNNP 74:743-748, Easey,A.J.,et al, 2003

Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage
Stroke 34:e45, ESPRIT, 2003

Major Risk Factors for Aneurysmal Subarrachnoid Hemorrhage in the Young are Modifiable
Stroke 34:1375-1381, Broderick,J.P.,et al, 2003

Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003

Abdominal Obesity and Risk of Ischemic Stroke
Stroke 34:1586-1592, Suk,S.,et al, 2003

A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003

Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003

Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
NEJM 349:1019-1026, Hylek,E.M.,et al, 2003

Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003

Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
Stroke 34:2741-2749, Rashid,P.,et al, 2003

Dietary Antioxidants and the Risk of Ischemic Stroke
Neurol 61:1273-1275, Voko,Z.,et al, 2003

Mechanisms of Stroke Protection by Physical Activity
Ann Neurol 54:582-590, Endres,M.,et al, 2003

Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003

Physical Activity and Stroke Risk
Stroke 34:2475-2482, Lee,C.D.,et al, 2003

A 50-Year-Old Woman With Atrial Fibrillation
JAMA 290:2182-2189, Singer,D.E., 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction.
AJNR 23:1757-1766, Brunberg,J.A.,et al, 2002

Association Between Influenza Vaccination and Reduced Risk of Brain Infarction
Stroke 33:513-518, LavalTe,P.,et al, 2002

Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise
Stroke 33:565-571,570, Greenlund,K.J.,et al, 2002

The PROGRESS Trial: Preventing Strokes by Lowering Blood Pressure in Patients With Cerebral Ischemia
Stroke 33:319-320, van Gijn,J., 2002

Ipsilateral Thalamic MRI Abnormality in an Epilepsy Patient
Neurol 58:641-644, Nagasaka,T.,et al, 2002

Clinicopath Conf, Hyperviscosity Syndrome Due to IgG Multiple Myeloma
NEJM 346:603-610, Case 6-2002, 2002

Diffusion-Weighted and Gradient Echo Magnetic Resonance Findings of Hemichorea-Hemiballismus Associated with Diabetic Hyperglycemia
Arch Neurol 59:448-452, Chu,K.,et al, 2002

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002

Emergent Use of Anticoagulation for Treatment of Patients with Ischemic Stroke
Stroke 33:856-861, Adams,H.P., 2002

Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002

Dietary Intake of Folate and Risk of Stroke in US Men and Women
Stroke 33:1183-1189, Bazzano,L.A.,et al, 2002

Gluten Sensitivity as a Neurological Illness
JNNP 72:560-563, Hadjivassiliou,M.,et al, 2002

Carotid Stenting and Endarterectomy
Stroke 33:1063-1070, Gray,W.A.,et al, 2002

Use of Ramipril in Preventing Stroke: Double Blind Randomised Trial
BMJ 324:699-702,687, Bosch,J.,et al, 2002

Prognostic Importance of Leukoaraiosis in Patients with Symptomatic Internal Carotid Artery Stenosis
Stroke 33:1651-1655, Streifler,J.Y.,et al, 2002

Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002

Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002

Serum Potassium Level and Dietary Potassium Intake as Risk Factors for Stroke
Neurol 59:314-320,302, Green,D.M.,et al, 2002

Clinical Features and ATTCT Repeat Expansion in Spinocerebellar Ataxia Type 10
Arch Neurol 59:1285-1290, Grewal,R.P.,et al, 2002

Blood Pressure Control in Stroke Patients
Neurol 59:23-25, Messerli,F.H.,et al, 2002

Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002

Transoesophageal Echocardiography in Selecting Patients for Anticoagulation After Ischaemic Stroke or Transient Ischaemic Attack
JNNP 73:29-33, Strandberg,M.,et al, 2002



Showing articles 350 to 400 of 894 << Previous Next >>